Myogenic Stem Cell Function Is Impaired in Mice Lacking the Forkhead/Winged Helix Protein MNF

Myocyte nuclear factor (MNF) is a winged helix transcription factor that is expressed selectively in myogenic stem cells (satellite cells) of adult animals. Using a gene knockout strategy to generate a functional null allele at the Mnf locus, we observed that mice lacking MNF are viable, but severel...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 97; no. 10; pp. 5416 - 5421
Main Authors Garry, Daniel J., Meeson, Annette, Elterman, Joel, Zhao, Yuhe, Yang, Peng, Bassel-Duby, Rhonda, Williams, R. Sanders
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences of the United States of America 09.05.2000
National Acad Sciences
The National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Myocyte nuclear factor (MNF) is a winged helix transcription factor that is expressed selectively in myogenic stem cells (satellite cells) of adult animals. Using a gene knockout strategy to generate a functional null allele at the Mnf locus, we observed that mice lacking MNF are viable, but severely runted. Skeletal muscles of Mnf-/- animals are atrophic, and satellite cell function is impaired. Muscle regeneration after injury is delayed and incomplete, and the normal timing of expression of cell cycle regulators and myogenic determination genes is dysregulated. Mnf mutant mice were intercrossed with mdx mice that lack dystrophin and exhibit only a subtle myopathic phenotype. In contrast, mdx mice that also lack MNF die in the first few weeks of life with a severe myopathy. Haploinsufficiency at the Mnflocus (Mnf+/-) also exacerbates the mdx phenotype to more closely resemble Duchenne's muscular dystrophy in humans. We conclude that MNF acts to regulate genes that coordinate the proliferation and differentiation of myogenic stem cells after muscle injury. Animals deficient in MNF may prove useful for evaluation of potential therapeutic interventions to promote muscle regeneration for patients having Duchenne's muscular dystrophy.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Edited by Richard D. Palmiter, University of Washington School of Medicine, Seattle, WA, and approved March 14, 2000
To whom reprint requests should be addressed at: University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, NB11.200, Dallas, TX 75390-8573. E-mail: garry@ryburn.swmed.edu.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.100501197